{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:32:53Z","timestamp":1758479573924,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":12,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071627716"},{"type":"electronic","value":"9781071627723"}],"license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2772-3_20","type":"book-chapter","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T18:07:03Z","timestamp":1668794823000},"page":"387-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exon-Skipping for a Pathogenic COL6A1 Variant in Ullrich Congenital Muscular Dystrophy"],"prefix":"10.1007","author":[{"given":"Sara","family":"Aguti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fady","family":"Guirguis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"B\u00f6nnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Bolduc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"issue":"19","key":"20_CR1","first-page":"3525","volume":"128","author":"M Cescon","year":"2015","unstructured":"Cescon M, Gattazzo F, Chen P, Bonaldo P (2015) Collagen VI at a glance. J Cell Sci 128(19):3525\u20133531","journal-title":"J Cell Sci"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","volume":"97","author":"AD Theocharis","year":"2016","unstructured":"Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK (2016) Extracellular matrix structure. Adv Drug Deliv Rev 97:4\u201327","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"20_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrneurol.2011.81","volume":"7","author":"CG Bonnemann","year":"2011","unstructured":"Bonnemann CG (2011) The collagen VI-related myopathies: muscle meets its matrix. Nat Rev Neurol 7(7):379\u2013390","journal-title":"Nat Rev Neurol"},{"issue":"386","key":"20_CR4","doi-asserted-by":"publisher","first-page":"eaal5209","DOI":"10.1126\/scitranslmed.aal5209","volume":"9","author":"BB Cummings","year":"2017","unstructured":"Cummings BB, Marshall JL, Tukiainen T, Lek M, Donkervoort S, Foley AR et al (2017) Improving genetic diagnosis in Mendelian disease with transcriptome sequencing. Sci Transl Med 9(386):eaal5209","journal-title":"Sci Transl Med"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.omtn.2020.05.029","volume":"21","author":"S Aguti","year":"2020","unstructured":"Aguti S, Bolduc V, Ala P, Turmaine M, Bonnemann CG, Muntoni F et al (2020) Exon-skipping oligonucleotides restore functional collagen VI by correcting a common COL6A1 mutation in Ullrich CMD. Mol Ther Nucleic Acids 21:205\u2013216","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"20_CR6","doi-asserted-by":"publisher","first-page":"e124403","DOI":"10.1172\/jci.insight.124403","volume":"4","author":"V Bolduc","year":"2019","unstructured":"Bolduc V, Foley AR, Solomon-Degefa H, Sarathy A, Donkervoort S, Hu Y et al (2019) A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies. JCI Insight 4(6):e124403","journal-title":"JCI Insight"},{"issue":"9","key":"20_CR7","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00439-017-1809-4","volume":"136","author":"R Vaz-Drago","year":"2017","unstructured":"Vaz-Drago R, Custodio N, Carmo-Fonseca M (2017) Deep intronic mutations and human disease. Hum Genet 136(9):1093\u20131111","journal-title":"Hum Genet"},{"issue":"14","key":"20_CR8","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1093\/nar\/gkw533","volume":"44","author":"MA Havens","year":"2016","unstructured":"Havens MA, Hastings ML (2016) Splice-switching antisense oligonucleotides as therapeutic drugs. Nucleic Acids Res 44(14):6549\u20136563","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"20_CR9","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000323","volume":"5","author":"DR Scoles","year":"2019","unstructured":"Scoles DR, Minikel EV, Pulst SM (2019) Antisense oligonucleotides: a primer. Neurol Genet 5(2):e323","journal-title":"Neurol Genet"},{"issue":"1","key":"20_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","volume":"14","author":"C Rinaldi","year":"2018","unstructured":"Rinaldi C, Wood MJA (2018) Antisense oligonucleotides: the next frontier for treatment of neurological disorders. Nat Rev Neurol 14(1):9\u201321","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"20_CR11","first-page":"433","volume":"9","author":"M Gagliardi","year":"2021","unstructured":"Gagliardi M, Ashizawa AT (2021) The challenges and strategies of antisense oligonucleotide drug delivery. Biomedicine 9(4):433","journal-title":"Biomedicine"},{"issue":"10","key":"20_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","volume":"19","author":"TC Roberts","year":"2020","unstructured":"Roberts TC, Langer R, Wood MJA (2020) Advances in oligonucleotide drug delivery. Nat Rev Drug Discov 19(10):673\u2013694","journal-title":"Nat Rev Drug Discov"}],"container-title":["Methods in Molecular Biology","Muscular Dystrophy Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2772-3_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T07:07:50Z","timestamp":1677654470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2772-3_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"ISBN":["9781071627716","9781071627723"],"references-count":12,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2772-3_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"19 November 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}